What To Know
- Haskal, a professor with the department of radiology and medical imaging at the University of Virginia Health System in Charlottesville, also recognized the authors of an additional 12 clinical and five laboratory papers for their contributions.
- , was honored with the award for outstanding clinical research paper for “Clinical and Economic Benefits of Stent Grafts in Dysfunctional and Thrombosed Hemodialysis Access Graft Circuits in the REVISE Randomized Trial.
The Journal of Vascular and Interventional Radiology (JVIR)—the Society of Interventional Radiology’s (SIR’s) peer-reviewed scientific journal—announced the 2019 JVIR Editor’s Best awards in the May issue of the journal, published online today. The annual awards, supported by SIR Foundation, were chosen by the editor after a comprehensive editorial board review of all papers submitted to JVIR during the prior year.
2019 JVIR EDITOR’S AWARD FOR OUTSTANDING CLINICAL STUDY
Belinda A. Mohr, Ph.D., was honored with the award for outstanding clinical research paper for “Clinical and Economic Benefits of Stent Grafts in Dysfunctional and Thrombosed Hemodialysis Access Graft Circuits in the REVISE Randomized Trial.”
In citing why this paper stood out, JVIR Editor-in-chief Ziv J Haskal, M.D., FSIR, said, “The analysis adds to the growing base of rigorous economic assessments of our interventional therapies. Hemodialysis costs billions of dollars in America. Our growing number of prospective controlled IR-led trials, such as in end-stage renal disease, allow this very type of essential research to help define the societal value of interventions for our patients.”
2019 JVIR EDITOR’S AWARD FOR OUTSTANDING LABORATORY INVESTIGATION
Yuchen Huo, MA, of the University of California San Diego, was honored with the award for outstanding laboratory investigation for “Stress Conditions Induced by Locoregional Therapies Stimulate Enrichment and Proliferation of Liver Cancer Stem Cells.”
“The downstream immunologic effects of thermal and transcatheter oncological treatments are being methodically fleshed out in the IR literature,” said Haskal. “One aspect is the under-recognized potential stimulatory effect of locoregional HCC treatments which might risk promulgating HCC stem cell proliferation, lessening overall cancer outcomes. This study described and quantified this very effect and defined a pathway for potentially suppressing it.”
Haskal, a professor with the department of radiology and medical imaging at the University of Virginia Health System in Charlottesville, also recognized the authors of an additional 12 clinical and five laboratory papers for their contributions. “In my decade as editor, this year marked a remarkably rich and diverse one for interventional radiologic research,” noted Haskal.
